## ALGM: Allegro MicroSystems, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-7.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($26.08)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- FMR, LLC: 14.8% (+0.8%)
- Capital Research Glo: 9.1% (+5.8%)
- JPMORGAN CHASE & CO: 8.4% (+93.0%)
- Vanguard Group Inc: 7.7% (+0.6%)
- Blackrock Inc.: 6.2% (-3.5%)

### Key Risks

1. Elevated short interest (10.5%): bears positioning against stock.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.25 indicates undervaluation relative to growth. Forward P/E 29.3x attractive for 85% earnings growth. Balance sheet: strong liquidity (3.9x), low leverage (D/E 0.46). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.3B |
| Beta | 1.62 |
| 52W Range | $16.38 - $38.45 |
| Short Interest | 10.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.25 |
| Forward P/E | 29.3 |
| Current P/E | 54.3 |
| YoY Growth | 85.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 7.9% to 0.7% (-7.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 (-1.6%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.74% (CS: 46) | Neutral |
| RSI_14 | 56.5 | Neutral |
| MACD Histogram | 0.48 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.012x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $28.48
- **Stop Loss:** $26.08 (8.4% risk)
- **Target:** $30.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 575
- **Position Value:** $16,376.00
- **Portfolio %:** 16.38%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $0.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.13 | +5.4% |
| 2025Q2 | $0.08 | $0.09 | +6.5% |
| 2025Q1 | $0.05 | $0.06 | +19.6% |
| 2024Q4 | $0.06 | $0.07 | +9.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*